NCITA is collaborating with clinical researchers across the UK to provide NCITA Repository, Imaging Clinical Trials Unit and QA/QC Unit support for multicentre clinical imaging biomarker studies.
NCITA infrastructure support is available to external partners from both academia and industry, provided the clinical research proposal meets the NCITA study eligibility criteria.
For more information on the study adoption application process, please contact us at ncita.general@ucl.ac.uk or using our contact form.
External Studies Adopted by the NCITA Infrastructure
Atovaquone with Radical Chemoradiotherapy in locally advanced NSCLC
NCITA Repository Unit
CRUK International Alliance for Cancer Early Detection Alliance (ACED)
NCITA Repository Unit
Re-IMAGINE
Prostate Cancer Screening – Inviting Men for Prostate Cancer Screening Using MRI
NCITA Repository Unit
NeuroSAFE PROOF Trial
A single blinded, multi-centre, feasibility study to evaluate the ability to randomise men with prostate cancer into a trial comparing NeuroSAFE Robotic assisted radical prostatectomy (RALP) to standard Robotic assisted radical prostatectomy
(RALP).
NCITA Imaging Clinical Trials Unit, NCITA Repository Unit
PRIME Trial
A study comparing bi-parametric MRI to multi-parametric MRI in the diagnosis of clinically significant prostate cancer.
NCITA Imaging Clinical Trials Unit, NCITA Repository Unit
LIBRA
Lung Nodule Imaging Biobank for Radiomics and AI Research
NCITA Repository Unit